Structure-based evaluation of non-nucleoside inhibitors with improved potency and solubility that target HIV reverse transcriptase variants

KM Frey, DE Puleo, KA Spasov, M Bollini… - Journal of medicinal …, 2015 - ACS Publications
The development of novel non-nucleoside inhibitors (NNRTIs) with activity against variants
of HIV reverse transcriptase (RT) is crucial for overcoming treatment failure. The NNRTIs …
被引用次数：52 相关文章

Structure-based evaluation of non-nucleoside inhibitors with improved potency and solubility that target HIV reverse transcriptase variants

KM Frey, D Puleo, KA Spasov, M Bollini, WL Jorgensen… - 2015 - ri.conicet.gov.ar
The development of novel non-nucleoside inhibitors (NNRTIs) with activity against variants
of HIV reverse transcriptase (RT) is crucial for overcoming treatment failure. The NNRTIs …

Structure-based evaluation of non-nucleoside inhibitors with improved potency and solubility that target HIV reverse transcriptase variants.

KM Frey, DE Puleo, KA Spasov, M Bollini… - Journal of Medicinal …, 2015 - europepmc.org
Structure-based evaluation of non-nucleoside inhibitors with improved potency and solubility that
target HIV reverse transcriptase variants. - Abstract - Europe PMC Sign in | Create an account …

Structure-based evaluation of non-nucleoside inhibitors with improved potency and solubility that target HIV reverse transcriptase variants

KM Frey, D Puleo, KA Spasov, M Bollini… - 2015 - datosdeinvestigacion.conicet.gov.ar
The development of novel non-nucleoside inhibitors (NNRTIs) with activity against variants
of HIV reverse transcriptase (RT) is crucial for overcoming treatment failure. The NNRTIs …

Structure-based evaluation of non-nucleoside inhibitors with improved potency and solubility that target HIV reverse transcriptase variants

KM Frey, D Puleo, KA Spasov, M Bollini… - 2015 - notablesdelaciencia.conicet.gov.ar
The development of novel non-nucleoside inhibitors (NNRTIs) with activity against variants
of HIV reverse transcriptase (RT) is crucial for overcoming treatment failure. The NNRTIs …
[HTML] nih.gov

[HTML][HTML] Structure-Based Evaluation of Non-nucleoside Inhibitors with Improved Potency and Solubility That Target HIV Reverse Transcriptase Variants

KM Frey, DE Puleo, KA Spasov, M Bollini… - Journal of Medicinal …, 2015 - ncbi.nlm.nih.gov
Structure-Based Evaluation of Non-nucleoside Inhibitors with Improved Potency and
Solubility That Target HIV Reverse Transcriptase Variants - PMC Back to Top Skip to main …

[引用][C] Structure-Based Evaluation of Non-nucleoside Inhibitors with Improved Potency and Solubility That Target HIV Reverse Transcriptase Variants

K Frey, D Puleo, K Spasov, M Bollini… - Journal of Medicinal …, 2015 - osti.gov
Structure-Based Evaluation of Non-nucleoside Inhibitors with Improved Potency and
Solubility That Target HIV Reverse Transcriptase Variants (Journal Article) | OSTI.GOV skip …
[PDF] psu.edu

[PDF][PDF] Structure-Based Evaluation of Non-nucleoside Inhibitors with Improved Potency and Solubility That Target HIV Reverse Transcriptase Variants

KM Frey, DE Puleo, KA Spasov, M Bollini… - J. Med. Chem, 2015 - Citeseer
The development of novel non-nucleoside inhibitors (NNRTIs) with activity against variants
of HIV reverse transcriptase (RT) is crucial for overcoming treatment failure. The NNRTIs …

Structure-based evaluation of non-nucleoside inhibitors with improved potency and solubility that target HIV reverse transcriptase variants

KM Frey, DE Puleo, KA Spasov… - Journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
The development of novel non-nucleoside inhibitors (NNRTIs) with activity against variants
of HIV reverse transcriptase (RT) is crucial for overcoming treatment failure. The NNRTIs …